Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03243292 · ClinicalTrials.gov registry record
Bronchial Thermoplasty 10+ Year Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 192
- Enrollment target
NCT03243292: Completed study, sponsored by Boston Scientific Corporation.
NCT03243292 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 192 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03243292 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 192 participants
- Enrollment target
Study Summary
To confirm the long-term efficacy and safety of Bronchial Thermoplasty (BT) at 10 years follow-up or beyond in subjects previously enrolled in any of the following Boston Scientific-sponsored, controlled pre-approval studies: AIR, RISA and AIR2.
Primary Outcome
Following BT, defined as bronchiectasis or bronchial stenosis, as confirmed by Pulmonary Volumetric HRCT scan at the BT 10+study visit in those3 subjects who had baseline Volumetric HRCT scan in the AIR2 study. Baseline and 10+ year HRCTs are to be read by an independent radiologist and also assessed by an independent pulmonologist.
Interventions
- OTHER Bronchial Thermoplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2017-12-11 |
| Est. Completion | 2019-01-10 |
What the finished NCT03243292 record still lists
NCT03243292 is an observational study that tracks outcomes without assigning an intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Bronchial Thermoplasty is the first listed.
NCT03243292 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03243292 about?
NCT03243292 is a clinical study titled "Bronchial Thermoplasty 10+ Year Study". To confirm the long-term efficacy and safety of Bronchial Thermoplasty (BT) at 10 years follow-up or beyond in subjects previously enrolled in any of the following Boston Scientific-sponsored, controlled pre-approval studies: AIR, RISA and AIR2.
What is the current status of trial NCT03243292?
This trial is currently completed. The enrollment target is 192 participants. The study started on 2017-12-11. Estimated completion is 2019-01-10.
What interventions are being tested in trial NCT03243292?
The interventions under investigation include: Bronchial Thermoplasty (OTHER).
Who is sponsoring clinical trial NCT03243292?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI